Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12417416 | 1.00 | LMNA (0.34) | LMNAPKMALDH1A1MAPTKMT2A | |
| SCHEMBL12417421 | 1.00 | LMNA (0.34) | LMNAPKMALDH1A1MAPTKMT2A | |
| SCHEMBL18963318 | 0.98 | LMNA (0.35) | LMNAPKMALDH1A1MAPTKMT2A | |
| SCHEMBL18963320 | 0.92 | ADRB2 (0.31) | LMNAPKM | |
| SCHEMBL18963376 | 0.90 | — | — | |
| SCHEMBL18963343 | 0.90 | — | — | |
| SCHEMBL12417417 | 0.88 | HPGD (0.33) | ALDH1A1POLB | |
| SCHEMBL18963268 | 0.81 | PKM (0.34) | PKM | |
| SCHEMBL18963373 | 0.81 | CES2 (0.39) | LMNAALDH1A1MAPTKMT2A | |
| SCHEMBL18963372 | 0.81 | PKM (0.34) | PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110195025-A1 | ANIONIC OLIGOSACCHARIDE CONJUGATES | GLYCAN BIOSCIENCES PTY LTD (AU) | 2011-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195025-A1 | ANIONIC OLIGOSACCHARIDE CONJUGATES | FUT6, FUT5, CSGALNACT1 | LMNA 3561/4885PKM 4147/4885ALDH1A1 2292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.